Abstract
Occipital nerve stimulation (ONS) continues to be investigated for the treatment of refractory chronic migraine. Results from case series and from prospective, sham-controlled clinical trials remain inconclusive regarding the efficacy of ONS for migraine treatment. Safety and implantation techniques require improvements since rates of lead migration, infection, and persistent stimulator-related pain continue to be high. Existing data justify further ONS trials with carefully chosen primary outcome(s), adequate statistical power, and improved surgical techniques.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 117-126 |
| Number of pages | 10 |
| Journal | Progress in neurological surgery |
| Volume | 29 |
| DOIs | |
| State | Published - 2015 |
Fingerprint
ASJC Scopus subject areas
- Surgery
- Clinical Neurology
Cite this
Occipital nerve stimulation for migraine : Update from recent multicenter trials. / Schwedt, Todd J; Green, A. Laine; Dodick, David William.
In: Progress in neurological surgery, Vol. 29, 2015, p. 117-126.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Occipital nerve stimulation for migraine
T2 - Update from recent multicenter trials
AU - Schwedt, Todd J
AU - Green, A. Laine
AU - Dodick, David William
PY - 2015
Y1 - 2015
N2 - Occipital nerve stimulation (ONS) continues to be investigated for the treatment of refractory chronic migraine. Results from case series and from prospective, sham-controlled clinical trials remain inconclusive regarding the efficacy of ONS for migraine treatment. Safety and implantation techniques require improvements since rates of lead migration, infection, and persistent stimulator-related pain continue to be high. Existing data justify further ONS trials with carefully chosen primary outcome(s), adequate statistical power, and improved surgical techniques.
AB - Occipital nerve stimulation (ONS) continues to be investigated for the treatment of refractory chronic migraine. Results from case series and from prospective, sham-controlled clinical trials remain inconclusive regarding the efficacy of ONS for migraine treatment. Safety and implantation techniques require improvements since rates of lead migration, infection, and persistent stimulator-related pain continue to be high. Existing data justify further ONS trials with carefully chosen primary outcome(s), adequate statistical power, and improved surgical techniques.
UR - http://www.scopus.com/inward/record.url?scp=84942516720&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84942516720&partnerID=8YFLogxK
U2 - 10.1159/000434662
DO - 10.1159/000434662
M3 - Article
C2 - 26393345
AN - SCOPUS:84942516720
VL - 29
SP - 117
EP - 126
JO - Progress in neurological surgery
JF - Progress in neurological surgery
SN - 0079-6492
ER -